5-HT2A
Showing 1 - 25 of >10,000
Atypical Antipsychotics inGeriatric Population: What is Role of
Recruiting
- Neutropenia
-
Strasbourg, FranceService de Pharmacie - Stérilisation - CHU de Strasbourg - Franc
Oct 27, 2023
Healthy Trial in Basel (Placebo, Mescaline 100mg, Mescaline 200mg)
Recruiting
- Healthy
- Placebo
- +5 more
-
Basel, BS, SwitzerlandUniversity Hospital Basel, Clinical Trial Unit
Aug 17, 2021
Acneiform Eruption Due to Chemical, Xerosis Cutis, Paronychia Trial (HT-001 2% Topical Gel, HT-001 1% Topical Gel, HT-001 0.5%
Not yet recruiting
- Acneiform Eruption Due to Chemical
- +2 more
- HT-001 2% Topical Gel
- +3 more
- (no location specified)
Dec 3, 2022
Depressive Symptoms, Depression, Alzheimer Trial in Baltimore (Psilocybin)
Recruiting
- Depressive Symptoms
- +3 more
-
Baltimore, MarylandBehavioral Pharmacology Research Unit
Mar 9, 2022
Basic Science Trial in Copenhagen (Psilocybine, Ketanserin)
Recruiting
- Basic Science
-
Copenhagen, DenmarkNeurobiology Research Unit, Rigshospitalet
Aug 11, 2022
Rabies (Healthy Volunteers) Trial in Bangkok, Khon Kaen (Purified vero rabies vaccine - serum free VRVg-2, Purified inactivated
Recruiting
- Rabies (Healthy Volunteers)
- Purified vero rabies vaccine - serum free VRVg-2
- +3 more
-
Bangkok, Thailand
- +2 more
May 10, 2022
Implication of 5-HT7 Receptor in Inflammatory Mechanisms in
Not yet recruiting
- Healthy
- Multiple Sclerosis
- Blood sample
-
Orléans, FranceCHR Orléans
Feb 16, 2023
Chemo-induced Nausea and Vomiting Trial in Chengdu (5HT3RA+Olanzapine, 5HT3RA+Olanzapine+Dexamethasone)
Recruiting
- Chemotherapy-induced Nausea and Vomiting
-
Chengdu, Sichuan, ChinaWest China Hospital, Sichuan University
Mar 27, 2023
Chemo-induced Nausea and Vomiting Trial in Worldwide (NEPA (300mg netupitant/0.5mg palonosetron), Granisetron, 2 mg (oral) or 1
Recruiting
- Chemotherapy-induced Nausea and Vomiting
- NEPA (300mg netupitant/0.5mg palonosetron)
- +2 more
-
Prague, Czechia
- +12 more
Nov 8, 2022
Parkinson Disease Trial in France (drug, behavioral, procedure)
Recruiting
- Parkinson Disease
- Active drug: pimavanserin 17mg (2 strength tablets)
- +9 more
-
Besançon, France
- +15 more
Jan 20, 2022
Cabozantinib Post First-line Immuno-oncology Checkpoint
Completed
- Advanced Renal Cell Carcinoma (aRCC)
-
Glasgow, United Kingdom
- +8 more
Jun 30, 2022
Venous Leg Ulcer, Leg Ulcers Venous, Leg Ulcer Trial in United Kingdom (geko™ medical device)
Active, not recruiting
- Venous Leg Ulcer
- +4 more
- geko™ medical device
-
Southsea, Portsmouth, United Kingdom
- +22 more
Aug 4, 2022
HPV Infection, CIN1 Trial in Belgium, Estonia, United Kingdom (ChAdOx1-HPV, MVA-HPV, Placebo)
Active, not recruiting
- HPV Infection
- CIN1
- ChAdOx1-HPV
- +2 more
-
Antwerp, Belgium
- +15 more
Jan 9, 2023
Gastrooesophageal Cancer Trial in United Kingdom (Trastuzumab deruxtecan)
Not yet recruiting
- Gastrooesophageal Cancer
- Trastuzumab deruxtecan
-
Southampton, Hampshire, United Kingdom
- +16 more
Jul 27, 2023
Breast Cancer, Chemo-induced Nausea and Vomiting Trial in Hanzhou (Aprepitant, Palonosetron, Fosaprepitant)
Not yet recruiting
- Breast Cancer
- Chemotherapy-induced Nausea and Vomiting
- Aprepitant
- +2 more
-
Hanzhou, Zhejiang, Chinathe Second Affiliated Hospital of Zhejiang Univercity School of
Apr 23, 2023
Squamous Cell Oesophageal Carcinoma Receiving Nivolumab as Part
Completed
- Esophageal Squamous Cell Carcinoma
- Nivolumab
-
Truro, Cornwall, United Kingdom
- +35 more
May 18, 2022
Cocaine Dependence Trial in Richmond (Mirtazapine 15 MG Oral Tablet)
Completed
- Cocaine Dependence
- Mirtazapine 15 MG Oral Tablet
-
Richmond, VirginiaVirginia Commonwealth University
Nov 19, 2021
Bronchiolitis Trial in Australia, Canada, New Zealand (Oral dexamethasone, Nebulized Epinephrine, Oral )
Recruiting
- Bronchiolitis
- Oral dexamethasone
- +5 more
-
Adelaide, Australia
- +11 more
Apr 27, 2022
Glioma Glioblastoma Multiforme Trial in United Kingdom (Standard of Care, Additional pre- and intra-operative imaging)
Recruiting
- Glioma Glioblastoma Multiforme
- Standard of Care
- Additional pre- and intra-operative imaging
-
Birmingham, United Kingdom
- +23 more
May 26, 2022
Intracerebral Hemorrhage Trial in United Kingdom (A&D BP Digital Blood Pressure Monitor (UA-767PBT-Ci) CE Declaration
Recruiting
- Intracerebral Hemorrhage
- A&D BP Digital Blood Pressure Monitor (UA-767PBT-Ci) CE Declaration UA-767PBT-Ci
-
Bath, United Kingdom
- +15 more
Sep 15, 2021
Trauma Injury Trial in United Kingdom, United States (Cryoprecipitate, Red Blood Cells, Plasma)
Active, not recruiting
- Trauma Injury
- Cryoprecipitate
- +4 more
-
Houston, Texas
- +24 more
Jan 13, 2022
Acute Respiratory Distress Syndrome Trial in Montréal (Placebo, Ondansetron Injection)
Not yet recruiting
- Acute Respiratory Distress Syndrome
- Placebo
- Ondansetron Injection
-
Montréal, Quebec, CanadaHôpital Sacré-Coeur de Montréal
Aug 22, 2022
Small Cell Carcinoma, Hypercalcaemic Type, Ovarian Cancer Trial in Toronto (Pembrolizumab)
Active, not recruiting
- Small Cell Carcinoma, Hypercalcaemic Type
- Ovarian Cancer
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Jan 8, 2023
Adverse Effect Trial (normal saline, Ondansetron 4 mg, Ondansetron 8 mg)
Not yet recruiting
- Adverse Effect
- normal saline
- +2 more
- (no location specified)
Jul 25, 2022